Owlet Future Growth
Future criteria checks 2/6
Owlet se prevé un crecimiento anual de los beneficios y los ingresos de 66% y 23.6%, respectivamente, mientras que el BPA aumentará de grow a 70.2%.
Key information
66.0%
Earnings growth rate
70.2%
EPS growth rate
| Medical Equipment earnings growth | 16.1% |
| Revenue growth rate | 23.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
Potential Upside For Owlet, Inc. (NYSE:OWLT) Not Without Risk
Feb 29
Owlet, Inc. (NYSE:OWLT) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 17Owlet Non-GAAP EPS of -$0.17, revenue of $17.4M
Nov 14Owlet seeks FDA medical device approval for its prescription monitor for infants
Oct 06Owlet GAAP EPS of -$0.11 beats by $0.12, revenue of $18.3M misses by $5.63M
Aug 11Owlet, Inc.: A Turnaround Opportunity With Upcoming Bullish Catalysts
Jun 14Owlet: At The Intersection Of Telehealth And Infants
Aug 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 113 | -4 | 7 | 8 | 1 |
| 12/31/2025 | 86 | -8 | 2 | 2 | 1 |
| 12/31/2024 | 75 | -10 | -1 | 0 | 1 |
| 12/31/2023 | 54 | -37 | -24 | -24 | N/A |
| 9/30/2023 | 45 | -49 | -32 | -32 | N/A |
| 6/30/2023 | 53 | -61 | -43 | -42 | N/A |
| 3/31/2023 | 58 | -63 | -64 | -63 | N/A |
| 12/31/2022 | 69 | -79 | -83 | -81 | N/A |
| 9/30/2022 | 55 | -84 | -79 | -77 | N/A |
| 6/30/2022 | 69 | -99 | -83 | -81 | N/A |
| 3/31/2022 | 75 | -93 | -64 | -61 | N/A |
| 12/31/2021 | 76 | -72 | -43 | -41 | N/A |
| 9/30/2021 | 99 | -53 | -41 | -40 | N/A |
| 6/30/2021 | 89 | -20 | -19 | -18 | N/A |
| 3/31/2021 | 82 | -16 | -8 | -7 | N/A |
| 12/31/2020 | 75 | -11 | -1 | 0 | N/A |
| 12/31/2019 | 50 | -18 | -18 | -16 | N/A |
Analyst Future Growth Forecasts
Ingresos vs. tasa de ahorro: OWLT se prevé que siga sin ser rentable en los próximos 3 años.
Beneficios frente mercado: OWLT se prevé que siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: OWLT se prevé que siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: OWLTSe prevé que los ingresos de la empresa (23.6% al año) crezcan más deprisa que los del mercado US (8.1% al año).
Ingresos de alto crecimiento: OWLTSe prevé que los ingresos de la empresa (23.6% al año) crezcan más deprisa que 20% al año.
Earnings per Share Growth Forecasts
Future Return on Equity
Futura rentabilidad financiera (ROE): Datos insuficientes para determinar si la Rentabilidad de los fondos propios de OWLT se prevé elevada dentro de 3 años.